Amrut Pharma MD Shailesh Joshi shoots himself dead after separation from wife

News Network
June 4, 2018

Belagavi, Jun 4: Shailesh Joshi, the managing director of Amrut Pharmaceuticals committed suicide by shooting himself in Belagavi. His relatives found his body on Monday morning.

Police officers, who spoke to his friends and family members, suspect he was upset over some issues in the family. “He was separated from his wife recently. He was fighting a divorce,” a police officer said.

According to his relatives, he was a very jolly and socially active person. But he was suffering from depression from a few months.

He supervised five for-profit ventures, and a charity. He had invested in or was involved in the management of Amrut pharma, Amrut Advertising, Sara Herbals, Progen Research labs and Saffron ventures — all based in Belagavi. They produce and sell Ayurvedic medicines, lifestyle products and mineral water. Apart from selling in various states, he exported his products to the middle East, and Russia.

Comments

Mohit Dubai
 - 
Monday, 4 Jun 2018

Very sad. Why the hell he should commit suicide if his wife ditches him? There are billions of women in the world

 

Nisha Belgami
 - 
Monday, 4 Jun 2018

Don’t know whether to mourn or not, because his tweets prove that he was a bhakt of namo and Arnab.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 11,2020

New Delhi, Jun 11: The Department of Pharmaceuticals has given its nod for lifting of ban on the export of hydroxychloroquine, Union Minister D V Sadananda Gowda said on Wednesday.

India had banned export of hydroxychloroquine on March 25, with some exceptions, amid views in some quarters that the drug could be used to fight COVID-19. On April 4, it completely banned the exports without any exception.

"Department of Pharmaceuticals has approved the lifting of ban on export of Hydroxychloroquine API as well as formulations. Manufacturers except SEZ/EOU Units have to supply 20 per cent production in the domestic market," the minister of chemicals and fertilisers said in a tweet.

The Directorate General of Foreign Trade (DGFT) has been asked to issue formal notification in this regard, he added.

In another tweet, Gowda said he held discussions with representatives of pharma companies along with some of his ministerial colleagues on the challenges being faced by the industry and on the roadmap to boost exports.

"Had detailed discussion with representatives of pharma companies & association, stakeholder Ministries along with Hon Ministers @piyushGoyal  ji, @HardeepSPuri  ji, & @MansukhMandviya  ji on entire gamut of challenges faced by the industry as well as strategies to boost pharma export," Gowda tweeted.

India exported hydroxychloroquine API (active pharmaceutical ingredient) worth USD 1.22 billion in April-January 2019-20.

During the same period, exports of formulations made from hydroxychloroquine was at USD 5.50 billion.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
July 15,2020

Kochi, Jul 15: Alisha P Shaji, a commerce student from Kerala's Kochi scored 499 out of 500 in the Central Board of Secondary Education (CBSE) class 12 results declared on Monday, wants to pursue a career in economics.

While talking to news agency on Tuesday, she said that she never joined coaching classes.

"I was surprised after knowing the unexpected result. I never expected this, I expected close to 98 per cent. I had five subjects to write but I could attempt only three as two were postponed. I am sad that I could not attempt them, but I am happy that I scored 100 in those subjects. In future, I want to pursue a degree in economics," she said.

"My friends, family and teachers are very supportive and I am thankful to them. I never went to tuitions. I used to study four to five hours a day," she added.

Alisha further said that she wants to give the message that it is okay to start late, but continuity is key to achieve good results.
CBSE on Monday had declared the results for Class 12 examinations 2020.

As per CBSE, with 88.78 per cent pass percentage this year for Class 12, the pass percentage has increased by 5.38 per cent. Last year, the pass percentage was 83.40 per cent. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 20,2020

Kalaburagi, Apr 20: With no COVID-19 case reported here on Sunday, the total number of virus-infected people in the district stood at 22.

While three persons have succumbed to the infection in the district so far, three others have been cured and discharged.

"No COVID-19 case was reported in Kalaburagi district today. Total 22 positive cases and 3 deaths have been reported in the district till date. Three persons have been cured," said District Magistrate B. Sharat.

Karnataka's total count of coronavirus patients has surged to 390, said the State Health Department on Sunday.

"Six new cases have been confirmed for COVID-19 in the State from 5 pm on Saturday till 5 pm on Sunday. Cumulatively, 390 COVID-19 positive cases have been confirmed in the state," it said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.